European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-29

Applied venomics of the cone snail species Conus consors for the accelerated, cheaper, safer and more ethical production of innovative biomedical drugs

Objectif

Venomous animals represent a major source of highly selective and efficient bioactive compounds that have already led to the development of several new drugs. The latest FDA approved example is Prialt, a peptide originating from the venom of a cone snail (Conus magus). CONCO is an innovative post-genomic project dedicated to the discovery and development of novel biopharmaceuticals generated by the broad biodiversity of cone snails.

The project aims at characterizing from the genomic up to potential therapeutic properties all the putative bioactive compounds that can be synthesised by a cone snail species. The genome and transcriptome of Conus consors will be exhaustively studied. Large amounts of venom will be fractionated and submitted to proteomic studies to generate a biochemically characterized 'natural library' of compounds. Large-scale synthesis of each identified candidate will be achieved to form a "synthetic library" of compounds.

Champ scientifique

Programme(s)

Thème(s)

Appel à propositions

FP6-2005-LIFESCIHEALTH-6
Voir d’autres projets de cet appel

Régime de financement

IP - Integrated Project

Coordinateur

ATHERIS LABORATORIES, DR RETO STÖCKLIN
Contribution de l’UE
Aucune donnée
Adresse
Chemin d'Alcire 1
PLAN-LES-OUATES - GENEVA
Suisse

Voir sur la carte
Liens
Coût total
Aucune donnée

Participants (19)

Partager cette page

Télécharger

Dernière mise à jour: 13 Février 2012

Mon livret

Permalink: https://cordis.europa.eu/project/id/37592/fr

European Union, 2024